Latest Insider Transactions at Eyenovia, Inc. (EYEN)
This section provides a real-time view of insider transactions for Eyenovia, Inc. (EYEN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of EYENOVIA, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of EYENOVIA, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 31
2022
|
Ellen R Strahlman Director |
BUY
Open market or private purchase
|
Direct |
6,686
+13.44%
|
$6,686
$1.62 P/Share
|
Aug 30
2022
|
Ellen R Strahlman Director |
BUY
Open market or private purchase
|
Direct |
6,744
+15.64%
|
$6,744
$1.6 P/Share
|
Aug 29
2022
|
Ellen R Strahlman Director |
BUY
Open market or private purchase
|
Direct |
7,931
+21.12%
|
$7,931
$1.62 P/Share
|
Aug 24
2022
|
Ellen R Strahlman Director |
BUY
Open market or private purchase
|
Direct |
1,504
+6.48%
|
$1,504
$1.59 P/Share
|
Aug 18
2022
|
Tsontcho Ianchulev Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,316
+3.42%
|
-
|
Jul 01
2022
|
Ram Palanki Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,187
+50.0%
|
-
|
Jul 01
2022
|
Ellen R Strahlman Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,187
+50.0%
|
-
|
Jun 21
2022
|
Stuart M. Grant |
BUY
Open market or private purchase
|
Direct |
100,000
+1.93%
|
$100,000
$1.65 P/Share
|
Jun 16
2022
|
Kenneth B Lee Jr |
BUY
Grant, award, or other acquisition
|
Direct |
22,222
+25.61%
|
-
|
Jun 16
2022
|
Rachel Jacobson Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,222
+46.55%
|
-
|
Jun 16
2022
|
Charles E Iv Mather Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,222
+23.95%
|
-
|
Jun 16
2022
|
Julia A Haller |
BUY
Grant, award, or other acquisition
|
Direct |
22,222
+42.22%
|
-
|
Jun 16
2022
|
Stephen Keith Benjamin |
BUY
Grant, award, or other acquisition
|
Direct |
22,222
+46.55%
|
-
|
May 19
2022
|
Kenneth B Lee Jr |
BUY
Open market or private purchase
|
Direct |
10,000
+19.11%
|
$20,000
$2.2 P/Share
|
May 18
2022
|
Charles E Iv Mather Director |
BUY
Open market or private purchase
|
Direct |
7,000
+12.65%
|
$14,000
$2.03 P/Share
|
May 11
2022
|
Stuart M. Grant |
BUY
Open market or private purchase
|
Direct |
25,000
+0.5%
|
$25,000
$1.95 P/Share
|
May 10
2022
|
Stuart M. Grant |
BUY
Open market or private purchase
|
Direct |
50,000
+1.0%
|
$50,000
$1.98 P/Share
|
May 05
2022
|
Stuart M. Grant |
BUY
Open market or private purchase
|
Direct |
25,926
+0.52%
|
$51,852
$2.26 P/Share
|
May 04
2022
|
Stuart M. Grant |
BUY
Open market or private purchase
|
Direct |
24,074
+0.49%
|
$48,148
$2.26 P/Share
|
Apr 22
2022
|
Stuart M. Grant |
BUY
Open market or private purchase
|
Direct |
20,000
+0.41%
|
$40,000
$2.55 P/Share
|
Apr 21
2022
|
Stuart M. Grant |
BUY
Open market or private purchase
|
Direct |
38,800
+0.79%
|
$77,600
$2.59 P/Share
|
Apr 11
2022
|
Stephen Keith Benjamin |
BUY
Grant, award, or other acquisition
|
Direct |
3,289
+50.0%
|
-
|
Apr 11
2022
|
Rachel Jacobson Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,289
+50.0%
|
-
|
Mar 31
2022
|
Charles E Iv Mather Director |
BUY
Open market or private purchase
|
Direct |
4,000
+8.83%
|
$12,000
$3.12 P/Share
|
Feb 22
2022
|
Stuart M. Grant |
BUY
Open market or private purchase
|
Direct |
42,000
+0.86%
|
$84,000
$2.75 P/Share
|
Feb 18
2022
|
Stuart M. Grant |
BUY
Open market or private purchase
|
Direct |
10,000
+0.21%
|
$20,000
$2.85 P/Share
|
Feb 07
2022
|
Stuart M. Grant |
BUY
Open market or private purchase
|
Direct |
36,030
+0.75%
|
$72,060
$2.97 P/Share
|
Dec 15
2021
|
Stuart M. Grant |
BUY
Open market or private purchase
|
Direct |
100,000
+2.07%
|
$300,000
$3.45 P/Share
|
Nov 17
2021
|
Curt H La Belle |
BUY
Grant, award, or other acquisition
|
Direct |
6,963
+14.15%
|
-
|
Nov 17
2021
|
Kenneth B Lee Jr |
BUY
Grant, award, or other acquisition
|
Direct |
6,963
+17.72%
|
-
|
Nov 17
2021
|
Ernest Mario |
BUY
Grant, award, or other acquisition
|
Direct |
6,963
+1.79%
|
-
|
Nov 17
2021
|
Charles E Iv Mather Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,963
+15.72%
|
-
|
Nov 17
2021
|
Anthony Y Sun |
BUY
Grant, award, or other acquisition
|
Direct |
6,963
+20.92%
|
-
|
Nov 17
2021
|
Fredric N Eshelman |
BUY
Grant, award, or other acquisition
|
Direct |
6,963
+0.53%
|
-
|
Nov 17
2021
|
Julia A Haller |
BUY
Grant, award, or other acquisition
|
Direct |
6,963
+45.96%
|
-
|
Nov 16
2021
|
Stuart M. Grant |
BUY
Open market or private purchase
|
Direct |
25,000
+0.54%
|
$75,000
$3.52 P/Share
|
Nov 15
2021
|
Stuart M. Grant |
BUY
Open market or private purchase
|
Direct |
75,000
+0.54%
|
$225,000
$3.64 P/Share
|
Nov 03
2021
|
Tsontcho Ianchulev Director |
BUY
Open market or private purchase
|
Direct |
30,000
+4.92%
|
$120,000
$4.04 P/Share
|
Nov 01
2021
|
Charles E Iv Mather Director |
BUY
Open market or private purchase
|
Direct |
4,000
+11.64%
|
$12,000
$3.83 P/Share
|
Oct 29
2021
|
Stuart M. Grant |
BUY
Open market or private purchase
|
Direct |
15,505
+0.17%
|
$46,515
$3.75 P/Share
|
Oct 27
2021
|
Michael M Rowe Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,200
+17.91%
|
$4,800
$4.14 P/Share
|
Oct 26
2021
|
Stuart M. Grant |
BUY
Open market or private purchase
|
Direct |
100,000
+2.16%
|
$400,000
$4.0 P/Share
|
Oct 25
2021
|
Stuart M. Grant |
BUY
Open market or private purchase
|
Direct |
33,806
+0.76%
|
$135,224
$4.0 P/Share
|
Sep 13
2021
|
Michael M Rowe Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,500
+25.86%
|
$6,000
$4.4 P/Share
|
Aug 19
2021
|
Stuart M. Grant |
BUY
Open market or private purchase
|
Direct |
50,000
+0.38%
|
$150,000
$3.97 P/Share
|
Aug 18
2021
|
Stuart M. Grant |
BUY
Open market or private purchase
|
Direct |
924
+0.01%
|
$2,772
$3.94 P/Share
|
Aug 17
2021
|
Stuart M. Grant |
BUY
Open market or private purchase
|
Direct |
23,419
+0.54%
|
$93,676
$4.0 P/Share
|
Jun 17
2021
|
Jennifer G Clasby VP, Regulatory and Clinical |
SELL
Payment of exercise price or tax liability
|
Direct |
14,262
-17.78%
|
$71,310
$5.42 P/Share
|
Jun 17
2021
|
Jennifer G Clasby VP, Regulatory and Clinical |
BUY
Exercise of conversion of derivative security
|
Direct |
24,510
+23.4%
|
$24,510
$1.95 P/Share
|
Jun 15
2021
|
Kenneth B Lee Jr |
BUY
Open market or private purchase
|
Direct |
2,000
+7.31%
|
$10,000
$5.41 P/Share
|